Medevien Presentation at MEDICA 2010


Published on

Business Analysis Presentation at MEDICA 2010 for h pylori marketplace

  • Be the first to comment

  • Be the first to like this

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

Medevien Presentation at MEDICA 2010

  1. 1. Business Plan Presentation MEDICA 2010MEDEVIEN SA Konstantine Haralampopoulos November 2010
  2. 2. Market Research for.. Healthcare Products – H.Pylori – PSA
  3. 3. Helicobacter pyloriGeneral Information: H.pylori causes conditions such as gastritis and ulcers in human beings. There is no immunisation for this type of bacterial infection and infection occurs as well in adults as in childs; however by suitable medication with antibiotics the bacterium can be killed. An infection with H.pylori also increases the chances of getting stomach cancer considerablyNational Infection rate: 50% of healthy adults affected – one in two people. The majority undiagnosedPotential Patients in Greece: 3.500.000 in Total PopulationCurrent Diagnostic pathway: Laboratory examinations only availableo biopsy via gastroscopyo breath testo blood and fecal examination for Antibody tracing (rarely)
  4. 4. Current Diagnostic pathway Laboratory examinations only available o biopsy via gastroscopy o breath test o blood and fecal examination for Antibody tracing (rarely) o Blood testing cost up to 30€ per examination in private labs
  5. 5. The Self-Diagnostic device• Stomach Ulcer Prevention test – the innovative self-testing solution – Simple, quick and painless – A new essential addition into the current diagnostic pathway – Accuracy rates comparable to all laboratory examination approaches
  6. 6. Stomach Ulcer self test Positives Negatives• First self-testing product in • Previous infection with the Greek market H.pylori can give a faulty• High Accuracy positive result• Easy to use • Low awareness on H.pylori• bacteria High market potential • Currently Immature market• Lack of direct competition in regards to self diagnosis • Possible conflict with Private Laboratories
  7. 7. H. Pylori - Target Audience Public 30+ years old, all socio-economic classes, throughout Greece. Selling/Purchasing Points  Pharmacies Doctors  Pathologists, General Practitioners, Gastroenterologists
  8. 8. Strategic Plan Objectives Strategies Tactics Design leaflets -Stomach Ulcer information leaflets for public Grow the market Create Awareness - Product leaflets for selling points and HP Establish the Promote product’s accuracy Sales & Promotional data and unique technical product Activities specifications in HPs Product’s introduction & detailing in Pharmacies and Gain Medical Activate Consumer targeted doctors Community’s dynamics Media-advertising campaign referrals Publicity in Professional magazines Exhibit in Medical Congress
  9. 9. Prostate CancerInfection rate: It is the most frequent malignancy for men above 45 years old. In Europe 7% of the total male population will develop the disease.Potential Market in Greece: 2.500.000 in Total Male PopulationCurrent Diagnostic pathway:o Clinical examination & DREo PSA (Cost per examination 80€-102€ in Private labs) o Regular level below 4 ng/mL o Suspicious level 4-10 ng/mL o Dangerous level above 10 ng/mLo Sonografyo Biopsy
  10. 10. The Self-Diagnostic device• PSA self-test – the new self-testing solution – Simple, quick and reliable – Qualitative results – 1st step for PSA identification
  11. 11. PSA self-test Positives Negatives• First self-testing product in • Immature market in regards to the Greek market self diagnosis • Not a complete examination with• High Accuracy specific quantitative results• Easy to use • A further PSA lab examination is• Time saving required in case of a positive result• Lack of direct competition • Its reliability might be questioned
  12. 12. PSA - Target Audience Male Public 45+ years old, all socio-economic classes, throughout Greece. Selling/Purchasing Points  Pharmacies Doctors  Urologists, General Practitioners.
  13. 13. Strategic Plan Objectives Strategies Tactics Design leaflets Penetrate the Sales & Promotional - Product leaflets for selling market Activities points and HPs Promote product’s value & convenience Establish the self Activate Consumer Product’s introduction & diagnostic solution dynamics detailing in Pharmacies and targeted doctors Gain Medical Publicity in Professional magazines Community’s Dynamic Media campaign referrals Exhibit in the National Urological congres
  14. 14. Healthcare products Rolling forecast in # of eaches Month Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec YEYear Type Fcast Fcast Fcast Fcast Fcast Fcast Fcast Fcast Fcast Fcast Fcast Fcast Total Fcast PSA 1000 1.000 1.500 2.000 3.000 3.000 2.000 1.000 2.500 3.500 3.500 2.500 26.5002011 H.pylori 500 750 1.000 1.000 500 1.000 1.500 2.000 1.500 9.750 PSA 3.000 3.500 4.000 4.000 5.000 5.000 3.000 2.000 3.000 4.500 5.000 4.000 46.0002012 H.pylori 2.000 2.000 3.000 3.000 3.500 3.500 3.000 2.000 3.000 3.500 4.000 3.000 35.500 Depending on our Strategic Planning impact, forecast can be revised upwards within Q2 2010
  15. 15. Thank you!